Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of UK prescription charges changing should United States pharmaceutical companies be able to raise their prices for UK patients and reduce those for US consumers post-Brexit, in the light of recent remarks by the President of the United States.

The Department has made no assessment.